Abnormalities in micturition: Difference between revisions

Jump to navigation Jump to search
Line 18: Line 18:
! colspan="3" rowspan="5" |Diseases
! colspan="3" rowspan="5" |Diseases
| colspan="9" |'''Clinical manifestations'''
| colspan="9" |'''Clinical manifestations'''
! colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
| colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
| colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
Line 26: Line 26:
|-
|-
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
|-
|-
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
Line 38: Line 38:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Ultrasonography
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Ultrasonography
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysuria
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysuria
Line 61: Line 60:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |often shows UTI in women
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |often shows UTI in women
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
Line 82: Line 80:
* [[Vesicles]]
* [[Vesicles]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aphthous ulcer|aphthous]] [[ulcer]] in mouth
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aphthous ulcer|aphthous]] [[ulcer]] in mouth
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
Line 119: Line 116:
* [[hydronephrosis]]
* [[hydronephrosis]]
* beaded necklace like in emphysematous cystitis
* beaded necklace like in emphysematous cystitis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Urine culture to sensitivity
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Urine culture to sensitivity
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N
Line 138: Line 134:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
Line 165: Line 160:
* Hypoechoic when there is edema(swollen kidney)
* Hypoechoic when there is edema(swollen kidney)
* Gas buubles in emphysematous pyelonephritis
* Gas buubles in emphysematous pyelonephritis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 185: Line 179:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Ultrasonography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Ultrasonography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
|-
|-
| style="background: #DCDCDC; text-align: center;" |[[Vulvovaginitis]]<ref name="pmid20461391">{{cite journal |vauthors=Esim Buyukbayrak E, Kars B, Karsidag AY, Karadeniz BI, Kaymaz O, Gencer S, Pirimoglu ZM, Unal O, Turan MC |title=Diagnosis of vulvovaginitis: comparison of clinical and microbiological diagnosis |journal=Arch. Gynecol. Obstet. |volume=282 |issue=5 |pages=515–9 |date=November 2010 |pmid=20461391 |doi=10.1007/s00404-010-1498-x |url=}}</ref>
| style="background: #DCDCDC; text-align: center;" |[[Vulvovaginitis]]<ref name="pmid20461391">{{cite journal |vauthors=Esim Buyukbayrak E, Kars B, Karsidag AY, Karadeniz BI, Kaymaz O, Gencer S, Pirimoglu ZM, Unal O, Turan MC |title=Diagnosis of vulvovaginitis: comparison of clinical and microbiological diagnosis |journal=Arch. Gynecol. Obstet. |volume=282 |issue=5 |pages=515–9 |date=November 2010 |pmid=20461391 |doi=10.1007/s00404-010-1498-x |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 207: Line 200:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Microbiological diagnosis
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Microbiological diagnosis
* Wet mount
* Wet mount
Line 230: Line 222:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N or show [[PID]] like feature
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N or show [[PID]] like feature
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N or show [[PID]] like feature
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N or show [[PID]] like feature
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Culture of vaginal discharge
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Culture of vaginal discharge
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[NAAT]] for gonocooccal cervicitis
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[NAAT]] for gonocooccal cervicitis
Line 241: Line 232:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Tender prostate
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* [[WBC]]
* [[Leukocyte esterase]]
* [[Nitrite|Ntrite]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Prostate massage for chronic prostatits leads to raised leukocytes in urine
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
| style="background: #DCDCDC; text-align: center;" |[[Epididymoorchitis]]
| style="background: #DCDCDC; text-align: center;" |[[Epididymoorchitis]]
Line 262: Line 255:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 283: Line 275:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 302: Line 293:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 322: Line 312:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 341: Line 330:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 361: Line 349:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 380: Line 367:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 403: Line 389:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 422: Line 407:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 442: Line 426:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 461: Line 444:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
Line 480: Line 462:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |

Revision as of 15:31, 25 July 2018

Micturation Abnormalities Microchapters

Overview

Causes

Differential Diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Overview

Classification

  • There is no established system for the classification of abnormalities in micturition.

Causes

  • The causes of abnormalities in micturition includes causes of dysuria and incontinence:

Abnormalities of Micturition Differential Diagnosis

Differentiating the diseases that can cause abnormality in micturition:

Abbreviations: N= Normal, UTI= Urinary tract infection, CBC= Complete blood count, CT= Computed tomography, IBS= Irritable bowel syndrome, DRE= Digital rectal examination, HSV= Herpes simplex virus,

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging
Fever Urinary symptoms Supra-pubic tenderness Skin lesions Other CBC Electrolytes Urinalysis Ultrasonography CT scan
Dysuria Frequency Dribbling Hesitancy Nocturia
Inflammatory Dermatological disorders Lichen sclerosus[1] + + Lichenified plaques N N often shows UTI in women N N Biopsy
Behcet's syndrome[2][3][4] + + + + aphthous ulcer in mouth N N N N N None
Infectious diseases Cystitis[5][6] + + + + + + + N Leukopenia N
  • Bladder wall thickening
  • Intraluminal gas in emphysematous cystitis
Urine culture to sensitivity N
Urethritis[7][8][9] + + + + + Leukocytosis N N N N Urethral swab for culture, NAAT N
Pyelonephritis[10][11] + + + + ± N Urgency Leukocytosis Hyperkalemia
  • Hypoechoic when there is edema(swollen kidney)
  • Gas buubles in emphysematous pyelonephritis
Diseases Fever Dysuria Frequency Dribbling Hesitancy Nocturia Suprapubic tenderness Skin lesions Other CBC Electrolytes Urinalysis Ultrasonography CT scan Gold standard Additional findings
Vulvovaginitis[12] ± + + + + Thick white discharge N N N N N Microbiological diagnosis
Cervicitis + ± + ± +
  • Erythematous
  • Friable
Thick yellow green pus Leukocytosis N WBC N or show PID like feature N or show PID like feature Culture of vaginal discharge NAAT for gonocooccal cervicitis
Prostatitis + + + + + + ± Tender prostate Leukocytosis N N N Prostate massage for chronic prostatits leads to raised leukocytes in urine
Epididymoorchitis + + +
Non-inflammatory Anatomic Urethral stricture
Benign prostatic hyperplasia (BPH) + + + + +
Drug Spermicides
Cyclophosphamide +
Gynecological Atrophic vaginitis
Endometriosis +
Malignancy Bladder cancer
Vulvovaginal cancer ±
Iatrogenic Genitourinary instrumentation +
Pelvic irradiation
Trauma ± ±

References

  1. Ventolini G, Patel R, Vasquez R (2015). "Lichen sclerosus: a potpourri of misdiagnosed cases based on atypical clinical presentations". Int J Womens Health. 7: 511–5. doi:10.2147/IJWH.S82879. PMC 4431497. PMID 26056492.
  2. Theodorou C, Floratos D, Hatzinicolaou P, Vaiopoulos G (August 1999). "Neurogenic bladder dysfunction due to Behçet's disease". Int. J. Urol. 6 (8): 423–5. PMID 10466456.
  3. Porru D, Pau AC, Scarpa RM, Zanolla L, Cao A, Usai E (May 1996). "Behçet's disease and the neuropathic bladder: urodynamic features: case report and a literature review". Spinal Cord. 34 (5): 305–7. PMID 8963981.
  4. Cetinel B, Akpinar H, Tüfek I, Uygun N, Solok V, Yazici H (January 1999). "Bladder involvement in Behçet's syndrome". J. Urol. 161 (1): 52–6. PMID 10037367.
  5. Grover S, Srivastava A, Lee R, Tewari AK, Te AE (February 2011). "Role of inflammation in bladder function and interstitial cystitis". Ther Adv Urol. 3 (1): 19–33. doi:10.1177/1756287211398255. PMC 3126088. PMID 21789096.
  6. Eken A, Alma E (2013). "Emphysematous cystitis: The role of CT imaging and appropriate treatment". Can Urol Assoc J. 7 (11–12): E754–6. doi:10.5489/cuaj.472. PMC 3840514. PMID 24282470.
  7. Glicksman, Joseph M. (1967). "Gonococcal Skin Lesions". Archives of Dermatology. 96 (1): 74. doi:10.1001/archderm.1967.01610010080015. ISSN 0003-987X.
  8. Siboulet, A. (1955). "Inclusion Bodies in Non-Gonococcal Urethritis, also Skin Lesions with Inclusions". Sexually Transmitted Infections. 31 (4): 235–237. doi:10.1136/sti.31.4.235. ISSN 1368-4973.
  9. Tsai, Chia-Chun; Li, Ching-Chia (2013). "Nonchlamydial nongonococcal urethritis in men". Urological Science. 24 (3): 73–77. doi:10.1016/j.urols.2013.06.001. ISSN 1879-5226.
  10. Gil-Ruiz MA, Alcaraz AJ, Marañón RJ, Navarro N, Huidobro B, Luque A (March 2012). "Electrolyte disturbances in acute pyelonephritis". Pediatr. Nephrol. 27 (3): 429–33. doi:10.1007/s00467-011-2020-9. PMID 21983846.
  11. Edell SL, Bonavita JA (September 1979). "The sonographic appearance of acute pyelonephritis". Radiology. 132 (3): 683–5. doi:10.1148/132.3.683. PMID 472247.
  12. Esim Buyukbayrak E, Kars B, Karsidag AY, Karadeniz BI, Kaymaz O, Gencer S, Pirimoglu ZM, Unal O, Turan MC (November 2010). "Diagnosis of vulvovaginitis: comparison of clinical and microbiological diagnosis". Arch. Gynecol. Obstet. 282 (5): 515–9. doi:10.1007/s00404-010-1498-x. PMID 20461391.